Grant: Travel Awards - Institute Community Support

Testicular cancer is the most common cancer to affect young men. Approximately 30% of patients will have progression of their cancer after undergoing initial surgery. Most patients will receive chemotherapy for their progression; however, retroperitoneal surgery has not been adequately explored for the treatment of progression of disease. This study demonstrates that most patients will achieve cure after receiving chemotherapy or surgery for their progression. Surgery as opposed to chemotherapy may avoid many of the long term complications of chemotherapy such as secondary cancers, heart disease, infertility, and hearing problems, and can be considered as a treatment option for progression in testicular cancer.